Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hirobumi Teraoka is active.

Publication


Featured researches published by Hirobumi Teraoka.


Stem Cells | 2003

Human Umbilical Cord Blood as a Source of Transplantable Hepatic Progenitor Cells

Sei Kakinuma; Yujiro Tanaka; Ryoko Chinzei; Mamoru Watanabe; Keiko Shimizu-Saito; Yuzuru Hara; Kenichi Teramoto; Shigeki Arii; Chifumi Sato; Kozo Takase; Takehiko Yasumizu; Hirobumi Teraoka

Human umbilical cord blood (UCB) cells have many advantages as grafts for cell transplantation because of the immaturity of newborn cells compared with adult cells. In contrast to their hematopoietic and mesenchymal potential, it remains unclear whether UCB cells have endodermal competence. Here, with a view to utilize UCB cells for cell transplantation into injured liver, we investigated the hepatic potential of UCB cells both in vitro and in vivo. We determined the most efficient conditions leading UCB cells to produce albumin (ALB). In a novel primary culture system supplemented with a combination of growth/differentiation factors, about 50% of UCB cells in 21‐day cultures expressed ALB, and the ALB+ cells coexpressed hepatocyte lineage markers. The ALB‐expressing cells were able to proliferate in the culture system. Moreover, in the cell‐transplantation model into liver‐injured severe combined immunodeficient mice, inoculated UCB cells developed into functional hepatocytes in the liver, which released human ALB into the sera of the recipient mice. In conclusion, this study demonstrates that human UCB is a source of transplantable hepatic progenitor cells. Our findings may have relevance to clinical application of UCB‐derived cell transplantation as a novel therapeutic option for liver failure.


Genes to Cells | 2004

Expression of the liver-specific gene Cyp7a1 reveals hepatic differentiation in embryoid bodies derived from mouse embryonic stem cells

Kinji Asahina; Hiroaki Fujimori; Keiko Shimizu-Saito; Yuji Kumashiro; Kentaro Okamura; Yujiro Tanaka; Kenichi Teramoto; Shigeki Arii; Hirobumi Teraoka

Hepatic differentiation from mouse embryonic stem (ES) cells via the formation of embryoid bodies (EBs) has been revealed by the expression of hepatocyte‐related genes such as α‐fetoprotein and albumin. It is known, however, that the visceral endoderm differentiates in early EBs and expresses these hepatocyte‐related genes. Thus, it remains unclear whether ES cells are capable of differentiating into hepatocytes derived from definitive endoderm in vitro. In the present study, yolk sac tissues isolated from the foetal mouse were found to express many hepatocyte‐related genes. Among the hepatocyte‐related genes examined, cytochrome P450 7A1 (Cyp7a1) was identified as a liver‐specific gene that was not expressed in the yolk sac. Cyp7a1 was induced in developing EBs, and hepatic differentiation was preferentially observed in the developing EBs in attached culture as compared to those in suspension culture. Leukaemia inhibitory factor permitted the differentiation of visceral endoderm, but inhibited the expression of gastrulation‐related genes and the hepatic differentiation in cultured EBs. ES cells expressing green fluorescent protein (GFP) under the control of the Cyp7a1 enhancer/promoter showed that cultured EBs contained GFP‐positive epithelial‐like cells. These results demonstrate that ES cells can differentiate in vitro into hepatocytes derived from definitive endoderm.


Biochemical and Biophysical Research Communications | 1985

Inhibition of DNA polymerase α, DNA polymerase β, terminal deoxynucleotidyl transferase, and DNA ligase II by poly(ADP-ribosyl)ation reaction in vitro☆

Koichiro Yoshihara; Asako Itaya; Yasuharu Tanaka; Yasuhiro Ohashi; Kimihiko Ito; Hirobumi Teraoka; Kinji Tsukada; Akio Matsukage; Tomoya Kamiya

Incubation of DNA polymerase α1, DNA polymerase β, terminal deoxynucleotidyl transferase, or DNA ligase II in a reconstituted poly(ADP-ribosyl)ating enzyme system markedly suppressed the activity of these enzymes. Components required for poly(ADP-ribose) synthesis including poly(ADP-ribose) polymerase, NAD+, DNA, and Mg2+ were all essential for the observed suppression. Purified poly(ADP-ribose) itself, however, was slightly inhibitory to all of these enzymes. Furtheremore, the suppressed activities of DNA polymerase α, DNA polymerase β, and terminal deoxynucleotidyl transferase were largely restored (3 to 4-fold stimulation was observed) by a mild alkaline treatment, a procedure known to hydrolyze alkaline-labile ester linkage between poly(ADP-ribose) and an acceptor protein. All of these results strongly suggest that the four nuclear enzymes were inhibited as a result of poly(ADP-ribosyl)ation of either the enzyme molecule itself or some regulatory proteins of these enzymes.


Molecular and Cellular Biology | 2007

RAD18 and poly(ADP-ribose) polymerase independently suppress the access of nonhomologous end joining to double-strand breaks and facilitate homologous recombination-mediated repair

Alihossein Saberi; Helfrid Hochegger; David Szuts; Li Lan; Akira Yasui; Julian E. Sale; Yoshihito Taniguchi; Yasuhiro Murakawa; Weihua Zeng; Kyoko Yokomori; Thomas Helleday; Hirobumi Teraoka; Hiroshi Arakawa; Jean Marie Buerstedde; Shunichi Takeda

ABSTRACT The Saccharomyces cerevisiae RAD18 gene is essential for postreplication repair but is not required for homologous recombination (HR), which is the major double-strand break (DSB) repair pathway in yeast. Accordingly, yeast rad18 mutants are tolerant of camptothecin (CPT), a topoisomerase I inhibitor, which induces DSBs by blocking replication. Surprisingly, mammalian cells and chicken DT40 cells deficient in Rad18 display reduced HR-dependent repair and are hypersensitive to CPT. Deletion of nonhomologous end joining (NHEJ), a major DSB repair pathway in vertebrates, in rad18-deficient DT40 cells completely restored HR-mediated DSB repair, suggesting that vertebrate Rad18 regulates the balance between NHEJ and HR. We previously reported that loss of NHEJ normalized the CPT sensitivity of cells deficient in poly(ADP-ribose) polymerase 1 (PARP1). Concomitant deletion of Rad18 and PARP1 synergistically increased CPT sensitivity, and additional inactivation of NHEJ normalized this hypersensitivity, indicating their parallel actions. In conclusion, higher-eukaryotic cells separately employ PARP1 and Rad18 to suppress the toxic effects of NHEJ during the HR reaction at stalled replication forks.


Immunity | 1999

Ku in the cytoplasm associates with CD40 in human B cells and translocates into the nucleus following incubation with IL-4 and anti-CD40 mAb.

Tomohiro Morio; Silva H. Hanissian; Leonard B. Bacharier; Hirobumi Teraoka; Shigeaki Nonoyama; Makoto Seki; Jun Kondo; Hiroyasu Nakano; Sang-Kyou Lee; Raif S. Geha; Junichi Yata

CD40 plays a critical role in survival, growth, differentiation, and class switching of B lymphocytes. Although Ku is required for immunoglobulin class switching, how CD40 signal transduction is coupled to Ku is still unknown. Here, we show that CD40 directly interacts with Ku through the membrane-proximal region of cytoplasmic CD40. Ku was confined to the cytoplasm in human primary B cells, and the engagement of CD40 on the B cells cultured in the presence of IL-4 resulted in the dissociation of Ku from CD40, translocation of Ku into the nucleus, and increase in the activity of DNA-dependent protein kinase. These findings indicate that Ku is involved in the CD40 signal transduction pathway and may play an important role in the CD40-mediated events.


Experimental Cell Research | 1990

Reversible G1 arrest in the cell cycle of human lymphoid cell lines by dimethyl sulfoxide

Masaji Sawai; Kozo Takase; Hirobumi Teraoka; Kinji Tsukada

Proliferation of human B- and T-lymphoid cell lines including Raji and Akata cells was found to be arrested at the G1 stage in the cell cycle by dimethyl sulfoxide (DMSO). The G1 arrest by DMSO occurred gradually and was completed within 96 h after addition of 1.5% DMSO concomitantly with a decrease in growth rate. Progression of G1-phase cells containing a larger amount of RNA into S-phase began 9-12 h after removal of DMSO. At 24 h, the DNA pattern of the cell cycle was similar to that of nontreated log-phase cells. The expression of six differentiation markers on the lymphoid cells was not appreciably changed by treatment with DMSO. On the other hand, the expression of transferrin receptor (one of the growth-related markers) on G1-phase cells 96 h after addition of DMSO was decreased to one-fourth that on log-phase cells and was completely restored 24 h after removal of DMSO. These results indicate that DMSO, known as an inducer of differentiation in several myeloid cell lines, acts as an agent inducing G1 arrest in the cell cycle of the lymphoid cells.


Oncogene | 2005

Parp-1 deficiency causes an increase of deletion mutations and insertions/rearrangements in vivo after treatment with an alkylating agent

Atsushi Shibata; Nobuo Kamada; Ken-ichi Masumura; Takehiko Nohmi; Shizuko Kobayashi; Hirobumi Teraoka; Hitoshi Nakagama; Takashi Sugimura; Hiroshi Suzuki; Mitsuko Masutani

Accumulated evidence suggests that Parp-1 is involved in DNA repair processes, including base excision repair, single-strand and double-strand break repairs. To understand the precise role of Parp-1 in genomic stability in vivo, we carried out mutation analysis using Parp-1 knockout (Parp-1−/−) mice harboring two marker genes, gpt and red/gam genes. Spontaneous mutant frequencies of both genes in the bone marrows and livers did not differ significantly between Parp-1−/− and Parp-1+/+ mice (P>0.05). After treatment with an alkylating agent, N-nitrosobis(2-hydroxypropyl)amine (BHP), the mutant frequency of the red/gam genes in the liver in Parp-1−/− mice was 1.6-fold higher than that in Parp-1+/+ mice (P<0.05). Categorization of the mutations revealed that deletions larger than 1 kb or those accompanying 1–5 bp insertions at the deletion junctions, as well as rearrangements, were more frequently observed in Parp-1−/− than in Parp-1+/+ mice (P<0.05, respectively). In contrast, mutant frequencies of the gpt gene in the livers of Parp-1−/− and Parp-1+/+ mice after BHP treatment were both elevated and there was no significant difference between the genotypes. These results indicate that Parp-1 is implicated in suppressing deletion mutations in vivo, especially those accompanying small insertions or rearrangements.


PLOS ONE | 2010

DNA Lesions Induced by Replication Stress Trigger Mitotic Aberration and Tetraploidy Development

Yosuke Ichijima; Ken-ichi Yoshioka; Yoshiko Yoshioka; Keitaro Shinohe; Hiroaki Fujimori; Junya Unno; Masatoshi Takagi; Hidemasa Goto; Masaki Inagaki; Shuki Mizutani; Hirobumi Teraoka

During tumorigenesis, cells acquire immortality in association with the development of genomic instability. However, it is still elusive how genomic instability spontaneously generates during the process of tumorigenesis. Here, we show that precancerous DNA lesions induced by oncogene acceleration, which induce situations identical to the initial stages of cancer development, trigger tetraploidy/aneuploidy generation in association with mitotic aberration. Although oncogene acceleration primarily induces DNA replication stress and the resulting lesions in the S phase, these lesions are carried over into the M phase and cause cytokinesis failure and genomic instability. Unlike directly induced DNA double-strand breaks, DNA replication stress-associated lesions are cryptogenic and pass through cell-cycle checkpoints due to limited and ineffective activation of checkpoint factors. Furthermore, since damaged M-phase cells still progress in mitotic steps, these cells result in chromosomal mis-segregation, cytokinesis failure and the resulting tetraploidy generation. Thus, our results reveal a process of genomic instability generation triggered by precancerous DNA replication stress.


Journal of Histochemistry and Cytochemistry | 2007

Twist Relates to Tubular Epithelial-Mesenchymal Transition and Interstitial Fibrogenesis in the Obstructed Kidney

Yujiro Kida; Kinji Asahina; Hirobumi Teraoka; Inna Gitelman; Tetsuji Sato

Epithelial-mesenchymal transition (EMT) is a critical step in renal fibrosis. It has been recently reported that a transcription factor, Twist, plays a pivotal role in metastasis of breast tumors by inducing EMT. In this study, we examined whether Twist relates to renal fibrogenesis including EMT of tubular epithelia, evaluating Twist expression level in the unilateral ureteral obstruction (UUO) model. Kidneys of mice subjected to UUO were harvested 1, 3, 7, and 10 days after obstruction. Compared with control kidneys, Twist mRNA-level significantly increased 3 days after UUO (UUO day 3 kidney) and further augmented until 10 days after UUO. Twist expression increased in tubular epithelia of the dilated tubules and the expanded interstitial areas of UUO kidneys, where cell-proliferating appearances were frequently found in a time-dependent manner. Although a part of tubular cells in whole nephron segment were immunopositive for Twist in UUO day 7 kidneys, tubular epithelia downstream of nephron more frequently expressed Twist than upstream of nephron. In UUO day 7 kidneys, some tubular epithelia were confirmed to coexpress Twist and fibroblast-specific protein-1, a marker for EMT, indicating that Twist is involved in tubular EMT under pathological state. Twist was expressed also in a number of α-smooth muscle actin-positive myofibroblasts located in the expanded interstitial area of UUO kidneys. From these findings, the present investigation suggests that Twist is associated with tubular EMT, proliferation of myofibroblasts, and subsequent renal fibrosis in obstructed kidneys.


FEBS Letters | 1996

CPP32/Yama/apopain cleaves the catalytic component of DNA-dependent protein kinase in the holoenzyme.

Hirobumi Teraoka; Yoshiko Yumoto; Fumiaki Watanabe; Kinji Tsukada; Akira Suwa; Masato Enari; Shigekazu Nagata

DNA‐dependent protein kinase (DNA‐PK) is composed of a 460‐kDa catalytic component (p460) and a DNA‐binding component Ku protein. Immunoblot analysis after treatment of Jurkat cells with anti‐Fas antibody demonstrated the cleavage of p460 concomitantly with an increase in CPP32/Yama/apopain activity. Recombinant CPP32/Yama/apopain specifically cleaved p460 in the DNA‐PK preparation that had been purified from Raji cells into 230‐ and 160‐kDa polypeptides, the latter of which was detected in anti‐Fas‐treated Jurkat cells. The regulatory component Ku protein was not significantly affected by CPP32/Yama/apopain. DNA‐PK activity was decreased with the disappearance of p460 in the incubation of DNA‐PK with CPP32/Yama/apopain. These results suggest that the catalytic component of DNA‐PK is one of the target proteins for CPP32/Yama/apopain in Fas‐mediated apoptosis.

Collaboration


Dive into the Hirobumi Teraoka's collaboration.

Top Co-Authors

Avatar

Kinji Tsukada

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Kinji Asahina

University of Southern California

View shared research outputs
Top Co-Authors

Avatar

Fumiaki Watanabe

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Keiko Shimizu-Saito

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Kenichi Teramoto

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Shigeki Arii

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yujiro Tanaka

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Kozo Takase

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Shuki Mizutani

Tokyo Medical and Dental University

View shared research outputs
Researchain Logo
Decentralizing Knowledge